mlHealth360

Technical white paper · Scaida BrainCT-ICH

Intracranial hemorrhage triage in the clinical worklist

Predictive value and the clinical purpose of prioritization

Read the full paper

Abstract

Intracranial hemorrhage (ICH) triage software is intended to identify studies for earlier radiologist review. Its value depends on whether a flag reaches the reader in time to change care. Sensitivity and specificity alone do not describe that opportunity. This paper uses the FDA clearance record for Scaida BrainCT-ICH, published clinical literature, and derived calculations to examine three linked quantities: the proportion of flags that are true, the number of flags generated, and hemorrhages receiving no automated prioritization.

At the reported sensitivity and specificity, a hypothetical population with 4.5% hemorrhage prevalence would generate about 147 flags per 1,000 processed studies, including 39 true flags, while six hemorrhages would remain unflagged. Selecting a higher-prevalence subgroup can improve predictive value and reduce total flags but also excludes some hemorrhages from automated triage. Routing decisions should therefore be based on timely review and coverage, not predictive value alone. An absent flag must never be used to lower a study’s clinical priority.

What the full paper covers

  • The full arithmetic behind predictive value, flag rate and unflagged hemorrhage.
  • Why raising predictive value can triple the hemorrhages left with no automated flag.
  • A local measurement plan built around earlier review, not predictive value.

Scaida BrainCT-ICH is FDA 510(k) cleared (K250694) for computer-assisted triage and notification of suspected intracranial hemorrhage on non-contrast head CT in adults aged 22 and above. Not for diagnostic use; it does not replace radiologist interpretation.

About BrainCT-ICH

Scaida BrainCT-ICH reads non-contrast head CT as it arrives, flags suspected intracranial hemorrhage and notifies the radiologist's worklist so those studies can be reviewed sooner. See the product page →

Read the full paper

Enter your details and we'll email you the PDF.

We'll use your details to send this paper and will not share them. See our Privacy Policy.